Alessandro Andriani
Frosinone, 03100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Investigation of Healthcare-Acquired Infections and Antimicrobial Resistance in an Italian Hematology Department before and during the COVID-19 Pandemic.
Journal: Microorganisms
Published: May 31, 2024
Spleen Involvement at Diagnosis of Multiple Myeloma: A Case Report and Literature Review.
Journal: Cancer reports (Hoboken, N.J.)
Published: April 04, 2024
Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital in Rome.
Journal: Mediterranean journal of hematology and infectious diseases
Published: January 22, 2024
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
Journal: Cancers
Published: June 21, 2023
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
Journal: Blood cancer journal
Published: January 11, 2023
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group.
Journal: Leukemia & lymphoma
Published: June 27, 2022
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas.
Journal: Hematological oncology
Published: March 23, 2022
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
Journal: Annals of hematology
Published: January 18, 2022
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.
Journal: Annals of hematology
Published: March 22, 2020
Last Updated: 09/26/2026